Smaller, cheaper, faster: where next for liquid biopsies?
While LB has the potential to reduce the need for invasive TB and expedite treatment decisions, its cost-effectiveness hinges on long-term clinical outcomes and healthcare resource utilization. In this scenario, 'new era platforms' endowed with advanced liquid handling technologies could not only improve its efficiency and reduce costs but also enable higher-throughput experiments with much larger sample sizes.
Authors
- Andrea Gottardo (ORCID: https://orcid.org/0009-0004-3321-2218)
- Tancredi Didier Bazan Russo (ORCID: https://orcid.org/0009-0007-5595-3924)
- Valerio Gristina (ORCID: https://orcid.org/0000-0002-2392-0470)
- Lucia Palumbo (ORCID: https://orcid.org/0000-0002-6206-0266)
- Giancarlo Troncone (ORCID: https://orcid.org/0000-0003-1630-5805)
- Viviana Bazan (ORCID: https://orcid.org/0000-0003-0939-255X)
- Francesca Rita Ogliari (ORCID: https://orcid.org/0000-0003-1594-2407)
- Claudia Scimone (ORCID: https://orcid.org/0009-0000-5623-121X)
- Giuseppe Badalamenti (ORCID: https://orcid.org/0000-0002-2478-8838)
- Lorena Incorvaia (ORCID: https://orcid.org/0000-0002-1199-7286)
- Pasquale Pisapia (ORCID: https://orcid.org/0000-0002-6429-0620)
- Antonio Galvano (ORCID: https://orcid.org/0000-0003-4365-5683)
- Gianluca Russo (ORCID: https://orcid.org/0000-0003-2698-9470)
- Francesco Pepe (ORCID: https://orcid.org/0000-0002-3144-3248)
- Antonio Dello Russo (ORCID: https://orcid.org/0000-0002-4370-2008)
- Umberto Malapelle
- Juliette Aimee Guerry
Institutions
- IRCCS Ospedale San Raffaele (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Expert Review of Molecular Diagnostics
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1080/14737159.2025.2534961
- Citations
- 1
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.94